Delivery Order SPE2DB20D2104-SPE2DB23FS63C
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.94 firm fixed-price delivery order is for the supply of Ropinirole HCL ER 8 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has a ceiling value of $1,668.36 and an ultimate completion date of December 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $1,199.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,990,774 tablets of Ropinirole HCL ER 2 mg, a medication used to treat Parkinson's disease. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed-price, non-set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $1,584.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ropinirole HCL ER 12 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease. The award has a ceiling value of $7,780.64 and an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,314.25 firm fixed-price contract is for the delivery of ROPINIROLE HCL ER 8 MG tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 2 MG tablets, a medication commonly used to treat Parkinson's disease and restless leg syndrome. The contract has a firm-fixed price of $1,292.25 and a completion date of June 18, 2025. This contract is not set aside and is open to full and open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ropinirole HCL ER 2 mg tablets (30-count packaging) with a ceiling value of $1,458.49. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract has an ultimate completion date of December 18, 2025, and performance will be conducted from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ropinirole is a...
- This federal contract award, valued at $1,570.56, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4 milligram Ropinirole Hydrochloride extended-release tablets, a generic medication used to treat Parkinson's disease. The ceiling value of the delivery order is $3,345.60 and the ultimate completion date is December...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS63CDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,373.64 Firm Fixed Price delivery order is for the supply of Ropinirole HCL ER 6 mg tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The contract has an ultimate completion date of March 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is a task order under that larger IDC. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 3/15/23 |